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Abstract
Background: We present a case to illustrate controversies in percutaneous drainage of infected,
perinephric haematoma in a tetraplegic patient, who had implantation of baclofen pump in anterior
abdominal wall on the same side as perinephric haematoma.
Case presentation: A 56-year-old male with C-4 tetraplegia had undergone implantation of
programmable pump in the anterior abdominal wall for intrathecal infusion of baclofen to control
spasticity. He developed perinephric haematoma while he was taking warfarin as prophylactic for
deep vein thrombosis. Perinephric haematoma became infected with a resistant strain of
Pseudomonas aeruginosa, and required percutaneous drainage. Positioning this patient on his
abdomen without anaesthesia, for insertion of a catheter from behind, was not a realistic option.
Administration of general anaesthesia in this patient in the radiology department would have been
hazardous.
Results and Conclusion: Percutaneous drainage was carried out by anterior approach under
propofol sedation. The site of entry of percutaneous catheter was close to cephalic end of baclofen
pump. By carrying out drainage from anterior approach, and by keeping this catheter for ten weeks,
we took a risk of causing infection of the baclofen pump site, and baclofen pump with a resistant
strain of Pseudomonas aeruginosa. The alternative method would have been to anaesthetise the
patient and position him prone for percutaneous drainage of perinephric collection from behind.
This would have ensured that the drainage track was far away from the baclofen pump with minimal
risk of infection of baclofen pump, but at the cost of incurring respiratory complications in a
tetraplegic subject.
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Background
Spasticity is a common problem in the patients with tetra-
plegia due to cervical spinal cord injury. Spasticity may
not be relieved by oral medications in a few patients, who
may then be considered for implantation of a program-
mable pump for continuous intrathecal infusion of ba-
clofen. Spinal cord injury patients who have undergone
implantation of a baclofen pump require special care
while performing procedures in the ipsilateral kidney. For
example, while carrying out extracorporeal lithotripsy of
renal calculus, which is on the same side as the baclofen
pump, precautions need to be taken in order to decrease
the risk of damage by shock waves to baclofen pump and
the tube [1]. Similarly, spinal cord injury patients with im-
planted baclofen pump require special attention when a
percutaneous procedure is performed in the ipsilateral
kidney or perinephric space in order to prevent infection
of the baclofen pump. We present a case to illustrate con-
troversies, which arose in clinical management of a spinal
cord injury patient who had implantation of a baclofen
pump for control of spasticity. This patient with tetraple-
gia had been taking warfarin, and developed spontaneous
perinephric haematoma. The haematoma became infect-
ed with a resistant strain of Pseudomonas aerugionsa. The
best approach for drainage of perinephric haemastoma
was the subject of debate, as there were advantages and
disadvantages with each treatment option.
Case presentation
A 56-year-old male sustained cervical spinal cord injury
and developed C-4 complete tetraplegia in May 2001. He
underwent implantation of a programmable pump for in-
trathecal delivery of baclofen, in the anterior abdominal
wall in October 2001. This tetraplegic patient was pre-
scribed warfarin to prevent deep vein thrombosis. He de-
veloped a spontaneous, right-sided, perinephric
haematoma, which became infected with a resistant strain
of Pseudomonas aeruginosa. The haematoma was located
on the same side as the baclofen pump. We were unsure
of the best approach for insertion of a percutaneous drain-
age catheter without unduly exposing the patient to the
risk of the procedure per se, or risk of infection spreading
from the perinephric space to baclofen pump.
The patient with cervical spinal cord injury had painful
shoulders. He was also suffering from severe trigeminal
neuralgia. He was a high-risk case for inhalation anaesthe-
sia on account of his neurological level, gross obesity,
poor venous access and especially so, in the setting of ra-
diology department. Positioning this patient on his abdo-
men without anaesthetising him, for insertion of a
catheter from behind into the perinephric space, was vir-
tually impossible. In the prone position, his voluntary
ventilation would have been inadequate. Further, a tube
for delivery of baclofen from the pump located in the an-
terior abdominal wall, to the subarachnoid space, coursed
around the abdomen to enter the theca posteriorly by the
side of L-3 spine.
Since the perinephric collection was presenting in the
lumbar region anteriorly, percutaneous drainage was car-
ried out by an anterior approach while the patient was ly-
ing supine. The patient received 3/4 ml of Cyclimorph-10
(morphine tartrate 10 mg and cyclizine tartrate 50 mg per
ml) as premedication. Target-controlled sedation with a
plasma concentration of propofol of 0.5 microgram/ml
was administered using a Graseby 3400 TCI pump during
the radiological procedure, which lasted about ten min-
utes.
A size 8 Fr. pigtail catheter was inserted through the ante-
rior abdominal wall into right perinephric space while the
patient was lying supine. The site of entry of percutaneous
catheter was close to the cephalic end of baclofen pump.
The position of the catheter as it emerged anteriorly from
the right perinephric space is shown in Figures 1 and 2.
The direction of exit of the catheter from the perinephric
space is quite different in this patient from that of a tradi-
tional approach for drainage of a kidney or perinephric
haematoma. In the classical approach for drainage of a
perinephric haematoma, the catheter would emerge pos-
teriorly from the perinephric space. The proximity of the
drainage catheter as it exits the anterior abdominal wall,
to the cephalic end of baclofen pump, is shown in the CT
Figure 1
CT of abdomen: Right kidney is enlarged and pushed for-
wards by the perinephric collection. In contrast to the right
kidney, the left kidney is in the normal location and has nor-
mal size. Percutaneous catheter, which drains the right per-
tinephric collection, is seen emerging anteriorly by the side
of right kidney.BMC Urology 2002, 2 http://www.biomedcentral.com/1471-2490/2/9
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scan of abdomen. (Figure 3). The catheter can be seen ex-
iting to the right of the cephalic end of the baclofen pump.
Clinical photograph of front of abdomen of this tetraple-
gic patient shows the precise anatomical location of the
catheter, as the catheter comes out of the anterior abdom-
inal wall. (Figure 4). A two dimensional relationship of
the pigtail catheter draining the perinephric haematoma
to the baclofen pump may be appreciated in the scano-
gram taken during CT of abdomen (Figure 5). The classi-
cal way of placing a pigtail catheter from behind for
drainage of a kidney is illustrated in figure 6. This photo-
graph was taken from another tetraplegic subject, who
had undergone percutaneous nephrostomy. For place-
ment of a pigtail catheter in the renal pelvis, this tetraple-
gic subject was positioned on his abdomen and the
puncture was made in the lumbar region posteriorly.
When figure 6 is compared with figure 4, the differences
between the anterior and posterior surgical approaches
become very obvious.
Starting from the day of radiological intervention, this pa-
tient received colistin, two million units every eight hours,
for eleven days. Eighteen days later, he was prescribed
amikacin one gram, every 24 hours, for seven days. The
skin around the pigtail catheter became slightly inflamed
and red. (Figures 4). After he had received colistin and
amikacin, a swab, taken from the site of pigtail catheter,
showed a heavy growth of Pseudomonas aeruginosa, which
was resistant to gentamicin, tazocin and tobramycin. The
drainage fluid from the pigtail catheter turned purulent
and culture yielded growth of Pseudomonas aeruginosa re-
sistant to gentamicin and tobramycin. When the patient's
Figure 2
CT of abdomen: The right kidney is enlarged. There is
perinephric collection behind the right kidney. The right kid-
ney is pushed forwards by the perinephric collection. The
catheter, which was inserted for drainage of perinephric col-
lection, is seen emerging from the abdominal cavity into the
anterior abdominal wall.
Figure 3
CT of abdomen: The cephalic end of the baclofen pump is
seen in the anterior abdominal wall. To the right of the
baclofen pump, is seen the pigtail catheter emerging from the
anterior abdominal wall. Behind the right kidney is the resid-
ual perinephric collection, which appears to have septa. In
the posterior abdominal wall just behind the right kidney, is
seen the tube which connects the baclofen pump located in
the anterior abdominal wall to the intrathecal catheter.
Figure 4
Clinical photograph of the abdomen (close-up view): The
surgical scar of implantation of baclofen pump is seen. The
pigtail catheter emerges close to the scar. The skin around
the pigtail catheter is red and angry-looking. Approximate
position of baclofen pump is marked on the skin with a pen.BMC Urology 2002, 2 http://www.biomedcentral.com/1471-2490/2/9
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clinical condition improved, we considered the option of
resiting the catheter from behind. By then, the perinephric
collection had become smaller; there were septa within
the perinephric space. Therefore, we did not remove the
catheter and resite it from the back.
The catheter was removed ten weeks after it had been in-
serted into the right perinephric space. Prior to removal of
the catheter, microbiology of pus, drained by the pigtail
catheter, showed a heavy growth of Pseudomonas aerugino-
sa sensitive to colistin, but resistant to gentamicin and
tazocin. A swab taken from the site of entry of the catheter,
which was inflamed, showed a heavy growth of Pseu-
domonas aeruginosa sensitive to colistin and amikacin, but
resistant to tazocin, gentamicin and tobramycin. After re-
moval of the catheter, the patient was prescribed amikacin
500 mg intravenously every 12 hours for five days and
then, colistin 2 million units 12 hourly for seven days on
the basis of the most recent microbiology reports. Twenty-
five days later, a sample of urine was sent for microbiol-
ogy. This showed growth of Pseudomonas aeruginosa sensi-
tive to colistin, but resistant to ciprofloxacin, ceftazidime,
imipenem and gentamicin. There has been no clinical ev-
idence of infection of the baclofen pump with Pseu-
domonas aeruginosa.
Discussion
In this patient, there were two options for drainage of
perinephric haematoma.
• Treatment plan 1
Endotracheal intubation and inhalation anaesthesia fol-
lowed by turning the patient from supine to prone posi-
tion. Then the patient would lie on his abdomen and
drainage of right perinephric haematoma could be carried
out in a traditional way. The point of insertion of a cathe-
ter would be located in the lumbar region on the back.
The advantages of choosing this treatment option were as
follow:
 The drainage catheter would be situated far away from
the baclofen pump, as the baclofen pump had been
placed in the anterior abdominal wall.
Figure 5
Scanogram of CT of abdomen shows baclofen pump, which
has been placed in the anterior abdominal wall on right side.
The tube, which delivers baclofen from the pump into the
subarachnoid space, courses around the abdominal wall from
the front to the back. A pigtail catheter is seen in the right
perinephric space.
Figure 6
Clinical photograph of another patient with cervical spinal
cord injury and tetraplegia: This patient underwent ileal con-
duit urinary diversion since he had a urinary fistula from the
prostatic urethra. Unfortunately, he developed stricture of
distal ureters and required percutaneous nephrostomy drain-
age on both sides. The nephrostomy catheter emerges from
the back. The location of the percutaneous nephrostomy
catheter represents the traditional approach for draining a
kidney or perinephric space, by inserting a catheter from the
loin posteriorly. Compare the position of nephrostomy cath-
eter of this patient with figure 4.
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 The risk of spread of infection from the perinephric
space to baclofen pump would be virtually non-existent.
The disadvantages of this option were the need to anaes-
thetise a C-4 tetraplegic subject. He could develop respira-
tory complications after inhalation anaesthesia. He might
require prolonged ventilatory support.
• Treatment plan 2
Drainage of perinephric haematoma could be performed
from an anterior approach while the patient was lying su-
pine. The tetraplegic patient would not require general an-
aesthesia for this procedure. Since the site of exit of the
percutaneous catheter would be close to the top end of ba-
clofen pump, there would be a significant risk of spread of
infection from the perinephric space to the site where ba-
clofen pump had been implanted. Thus we had to balance
the advantages and risks involved in the two options. The
risks associated with these two treatment plans are sum-
marised below.
Risks of treatment plan 1: risks of inhalation anaesthe-
sia, possibility of prolonged ventilation, and post-proce-
dure respiratory complications
Risks of treatment plan 2: potential risk of infection of
baclofen pump site with a resistant strain of Pseudomonas
aeruginosa
We chose treatment option 2 because we believed that the
risks of inhalation anaesthesia and the occurrence of post-
procedure respiratory complications in a C-4 tetraplegic
subject were substantial. We were hopeful that with ap-
propriate antibiotic therapy, spread of infection from the
perinephric space to the site of implantation of baclofen
pump could be prevented. It is likely that some physicians
may have decided to anaesthetise the patient, place the
patient in a prone position, and then the radiologist
would have carried out placement of a pigtail catheter
from paraspinal region for drainage of perinephric hae-
matoma. In hindsight, we could have used a more lateral
approach for drainage of perinephric haematoma so that
the pigtail catheter is more distant to the implanted pump
and this would not have required prone positioning.
Thus, the treatment plan is open to debate.
Conclusion
By carrying out drainage of infected perinephric haemato-
ma by an anterior approach under sedation without ad-
ministering general anaesthesia, and by keeping this
catheter in place for ten weeks, we took a risk of causing
infection of the baclofen pump site, and baclofen pump
with a resistant strain of Pseudomonas aeruginosa. But the
patient did not develop any respiratory complications.
The alternative method of treatment would have been to
anaesthetise the patient and position him prone for per-
cutaneous drainage of perinephric collection from be-
hind. This would have ensured that the drainage track was
far away from the baclofen pump with minimal risk of in-
fection of baclofen pump, but at the cost of incurring res-
piratory complications in a tetraplegic subject.
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